Stockscreener 앱 받기
13.33
0.38%
0.05
전일 마감가:
$13.28
열려 있는:
$13.3317
하루 거래량:
320
Relative Volume:
0.01
시가총액:
$64.48M
수익:
$2.61M
순이익/손실:
$1.69M
주가수익비율:
44.39
EPS:
0.3003
순현금흐름:
-
1주 성능:
+3.90%
1개월 성능:
+12.21%
6개월 성능:
+67.04%
1년 성능:
+46.00%
1일 변동 폭
$13.33
$13.33
1주일 범위
$12.52
$13.33
52주 변동 폭
$6.55
$14.00
Daxor Corporation Stock (DXR) Company Profile
명칭
Daxor Corporation
전화
212-330-8500
주소
Empire State Building, Suite 7120 350 Fifth Avenue, New York, NY
DXR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DXR
Daxor Corporation
|
13.33 | 66.19M | 2.61M | 1.69M | 0 | 0.3003 |
|
ISRG
Intuitive Surgical Inc
|
458.57 | 164.35B | 9.15B | 2.63B | 1.99B | 7.1661 |
|
BDX
Becton Dickinson Co
|
190.17 | 54.75B | 21.39B | 1.61B | 2.55B | 5.5609 |
|
RMD
Resmed Inc
|
267.57 | 39.61B | 5.15B | 1.40B | 1.65B | 9.5082 |
|
ALC
Alcon Inc
|
75.38 | 37.31B | 10.03B | 1.07B | 1.39B | 2.1549 |
|
WST
West Pharmaceutical Services Inc
|
276.76 | 19.77B | 2.96B | 487.70M | 344.00M | 6.6758 |
Daxor Corporation Stock (DXR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2019-05-16 | 개시 | Ascendiant Capital Markets | Buy |
Daxor Corporation 주식(DXR)의 최신 뉴스
Daxor Corporation to Participate in Exclusive Maxim Growth Summit Featuring 40 Promising Healthcare Companies - Quiver Quantitative
Daxor CEO Michael Feldschuh to Engage Investors at Exclusive Maxim Growth Summit - GlobeNewswire
Why analysts raise outlook for Daxor Corporation (DX5) stock2025 Momentum Check & High Win Rate Trade Alerts - newser.com
Will Daxor Corporation (DX5) stock extend growth storyJuly 2025 Pullbacks & Weekly High Return Opportunities - newser.com
Will Daxor Corporation (DX5) stock outperform benchmarksJuly 2025 Analyst Calls & Scalable Portfolio Growth Ideas - newser.com
Can technical indicators confirm Daxor Corporation’s reversalWeekly Trade Report & Detailed Earnings Play Strategies - newser.com
How Daxor Corporation (DX5) stock behaves under inflation pressure2025 Historical Comparison & Fast Entry High Yield Tips - nchmf.gov.vn
How strong is Daxor Corporation (DX5) stock earnings growthWeekly Stock Recap & Weekly High Return Forecasts - newser.com
Is Daxor Corporation (DX5) stock attractive for dividend growthMarket Risk Analysis & Fast Entry High Yield Tips - nchmf.gov.vn
Is Daxor Corporation stock a buy before product launchesPortfolio Value Summary & Weekly Consistent Profit Watchlists - newser.com
Can Daxor Corporation (DX5) stock retain market dominance2025 Trade Ideas & Reliable Intraday Trade Plans - newser.com
Why Daxor Corporation (DX5) stock could rally stronglyTrade Volume Summary & Fast Exit Strategy with Risk Control - newser.com
Chart overlay techniques for tracking Daxor Corporation2025 Valuation Update & Trade Opportunity Analysis Reports - newser.com
Sector ETF performance correlation with Daxor CorporationWeekly Profit Report & Fast Gaining Stock Reports - newser.com
What earnings revisions data tells us about Daxor Corporation2025 Top Gainers & Daily Chart Pattern Signal Reports - newser.com
Will Daxor Corporation stock maintain dividend yieldJuly 2025 Rallies & Free Safe Entry Trade Signal Reports - newser.com
Head-To-Head Comparison: Bioqual (OTCMKTS:BIOQ) and Daxor (NASDAQ:DXR) - Defense World
Is Daxor Corporation reversing from oversold territory2025 Technical Overview & Weekly High Return Stock Forecasts - newser.com
Is Daxor Corporation stock poised for growthExit Point & Weekly Watchlist for Hot Stocks - newser.com
Can Daxor Corporation stock beat analyst upgradesPortfolio Value Summary & Weekly Return Optimization Plans - nchmf.gov.vn
Quarterly Risk: Is Daxor Corporation (DX5) stock undervalued by metricsWeekly Trend Recap & Safe Entry Trade Reports - nchmf.gov.vn
Daxor to exhibit at the MedAxiom CV Transforum Fall’25 Conference - MSN
Using data filters to optimize entry into Daxor CorporationIPO Watch & High Return Stock Watch Alerts - newser.com
Full technical analysis of Daxor Corporation stockDividend Hike & Weekly High Return Stock Forecasts - newser.com
Daxor (DXR) to Showcase at Cardiovascular Conference in Austin - GuruFocus
Daxor’s New BVA Technology To Be Showcased At MedAxiom CV Transforum Fall '25 - GlobeNewswire
Next‑Gen BVA System: Daxor Debuts Blood‑Volume Diagnostic at MedAxiom CV Transforum Oct 16–18 - Stock Titan
[N-CSR/A] – DAXOR CORP (DXR) (CIK 0000027367) | DXR SEC FilingForm N-CSR/A - Stock Titan
Using fundamentals and technicals on Daxor CorporationJuly 2025 WrapUp & Weekly Sector Rotation Insights - newser.com
Can Daxor Corporation stock sustain free cash flow growthJuly 2025 Intraday Action & Weekly Chart Analysis and Trade Guides - newser.com
Daxor Corporation (DXR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.93%
2.03%
자본화:
|
볼륨(24시간):